The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
Conclusions: Inhaled insulin appears to be effective, well tolerated, and well accepted in patients with type 2 diabetes and provides glycemic control comparable to a conventional subcutaneous ...
By Adam Nossiter Reporting from Paris The one-on-one duel that has shaped French political life for nearly a decade ratcheted up a notch last week, with the far-right leader Marine Le Pen claiming ...
After slashing the U.S. prices of several of its insulin products by 75% at the start ... which is a pre-filled, disposable pen, will fall from $559 to $140. For Tresiba’s U-100 FlexTouch ...
Zepbound comes as a liquid solution inside prefilled injection pens. You’ll inject the drug under your skin once per week. Zepbound is a brand-name medication. It contains the active ingredient ...
A federal jury has sided with Insulet, which claimed that the South Korea-based diabetes tech company EOFlow had stolen trade secrets related to its wearable insulin pump, in a case that ...
This recall relates to the company’s Monoject U-100 mL insulin syringe luer lock with tip cap soft pack (extended conical tip). The device is used to administer insulin under the skin (subcutaneous) ...
In our November research highlights, we look at how diet in early childhood is linked to the risk of type 2 diabetes years later, and how new clinical trials are looking to give people with type 1 ...
The medical device manufacturer Owen Mumford has announced that it will stop producing its Autopen range of insulin delivery pens. Here, we look at what this means for people with diabetes who might ...
Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback